US FDA

21 CFR 211.115 - Reprocessing

Plain-language explanation, inspection context and common violation patterns.

What it says

Written procedures must describe the circumstances and manner in which reprocessing of a batch that does not conform to standards or specifications may occur, and reprocessed batches must be examined and tested to demonstrate they meet all applicable standards, specifications and characteristics before disposition.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

Reprocessing occurring without a documented, specific procedure governing it, or reprocessing being used routinely for a given product in a way that suggests the underlying process is not actually capable of producing conforming material on a first pass.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →